<p>BIT Capital GmbH 在最近向美国证券交易委员会提交的 13F 文件中表示，在第四季度将其在 Oscar Health, Inc. (NYSE:OSCR - 免费报告) 的持股比例提高了 545.0%。该公司在本季度额外购买了 5,227,152 股后，持有该公司 6,186,267 股股票。Oscar Health 占 BIT Capital GmbH 投资组合的 3.3%，成为其第 12 大持股。根据其最近向美国证券交易委员会提交的文件，BIT Capital GmbH 持有约 2.34% 的 Oscar Health，价值 88,897,000 美元。</p>
<ul>
<li>5 只具有爆炸性上涨潜力的小型股</li>
</ul>
<p>其他几家对冲基金也对 OSCR 的持仓进行了调整。Quarry LP 在第三季度将其在 Oscar Health 的持仓增加了 439.8%。Quarry LP 目前持有 1,803 股该公司的股票，价值 34,000 美元，此前在上个季度额外购买了 1,469 股。Jones Financial Companies Lllp 在第一季度将其在 Oscar Health 的持仓增加了 7,473.3%。Jones Financial Companies Lllp 目前持有 2,272 股该公司的股票，价值 30,000 美元，此前在上个季度额外购买了 2,242 股。Strs Ohio 在第一季度获得了 Oscar Health 的新持仓，价值约 30,000 美元。Fifth Third Bancorp 在第四季度将其在 Oscar Health 的持仓增加了 148.7%。Fifth Third Bancorp 目前持有 2,363 股该公司的股票，价值 34,000 美元，此前在上个季度额外购买了 1,413 股。最后，Binnacle Investments Inc 在第二季度购买了价值约 75,000 美元的 Oscar Health 股票。当前 75.70% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>Oscar Health 关键新闻</h2>
<p>以下是本周影响 Oscar Health 的关键新闻：</p>
<ul>
<li>积极情绪：富国银行将 Oscar Health 从 <strong>“强烈卖出” 上调至 “持有”</strong>，尽管其 20 美元的目标价仍低于当前股价，但缓解了看空情绪。Zacks.com</li>
<li>积极情绪：Oscar Health 最近的财报显示 <strong>大幅超出每股收益预期</strong>，尽管收入低于预期，但支持了该股的基本面故事。</li>
<li>中性情绪：一位公司联合创始人转任 <strong>顾问领导角色</strong>，看起来更像是内部重组，而不是颠覆性变化。Oscar Health 联合创始人转任顾问领导角色</li>
<li>中性情绪：多位内部人士，包括 <strong>首席财务官 Richard Scott Blackley</strong> 和 <strong>首席行政官 Victoria Baltrus</strong>，根据预先计划的 10b5-1 计划出售股票，以覆盖已归属股权奖励的税务义务，这比自愿出售的担忧要小。</li>
<li>消极情绪：董事 <strong>Mario Schlosser</strong> 出售了 <strong>34,120 股</strong>，这是最新一批中最大的一笔内部出售，尽管是预先安排的，但可能会对情绪造成压力。</li>
</ul>
<h2>Oscar Health 股票表现</h2>
<p>OSCR 周五开盘价为 24.59 美元。该公司的市值为 74.1 亿美元，市盈率为 -41.68，市盈增长比率为 1.65，贝塔值为 2.37。该公司的债务与股本比率为 0.26，流动比率为 1.11，速动比率为 1.11。该股票的 50 日简单移动平均线为 18.39 美元，200 日简单移动平均线为 16.06 美元。Oscar Health, Inc. 的 1 年最低价为 10.69 美元，1 年最高价为 25.58 美元。</p>
<p>Oscar Health (NYSE:OSCR - 获取免费报告) 最近于 5 月 6 日发布了季度财报。该公司报告本季度每股收益为 2.07 美元，超出分析师一致预期的 1.11 美元，超出幅度为 0.96 美元。Oscar Health 的股本回报率为 -3.26%，净利润率为 -0.30%。该业务本季度的收入为 46.5 亿美元，而分析师预期为 49 亿美元。去年同期，该公司每股收益为 0.92 美元。与去年同期相比，该公司的收入增长了 52.6%。整体来看，股票分析师预计 Oscar Health, Inc. 本财年将发布 0.47 美元的每股收益。</p>
<h2>分析师评级变动</h2>
<p>OSCR 最近成为多份研究报告的主题。Raymond James Financial 将 Oscar Health 的评级从 &#34;市场表现&#34; 上调至 &#34;跑赢大盘&#34;，并在 2 月 12 日的研究报告中设定了 18.00 美元的目标价。Weiss Ratings 在 4 月 21 日的研究报告中重申了对 Oscar Health 股票的 &#34;卖出 (d)&#34; 评级。富国银行在周四设定了 Oscar Health 的 20.00 美元目标价，并给予该公司 &#34;等权重&#34; 评级。Wall Street Zen 在周六的报告中将 Oscar Health 的评级从 &#34;强力买入&#34; 下调至 &#34;买入&#34;。最后，Zacks Research 在 5 月 7 日的研究报告中将 Oscar Health 的评级从 &#34;持有&#34; 上调至 &#34;强力买入&#34;。一位研究分析师对该股票给予了强力买入评级，两位给予了买入评级，八位给予了持有评级，一位给予了卖出评级。根据 MarketBeat 的数据，该公司目前的共识评级为 &#34;持有&#34;，共识目标价为 20.22 美元。</p>
<p><strong>查看我们关于 OSCR 的最新报告</strong></p>
<h2>Oscar Health 的内部活动</h2>
<p>在关于 Oscar Health 的其他消息中，首席执行官 Mark T. Bertolini 于 4 月 6 日星期一购买了 1,000,000 股 Oscar Health 股票。每股的平均购买价格为 11.92 美元，总价值为 11,920,000.00 美元。购买后，首席执行官直接持有公司 10,196,876 股，价值为 121,546,761.92 美元。这笔交易代表了其持股比例的 10.87% 的增加。此次收购在向证券交易委员会的法律文件中披露，该文件可在 SEC 网站上查阅。此外，董事 Mario Schlosser 于 6 月 2 日星期二出售了 34,120 股该股票。股票的平均售价为 21.94 美元，总价值为 748,592.80 美元。交易后，该董事直接持有公司 480,866 股，价值约为 10,550,200.04 美元。这代表其持股比例的 6.63% 的减少。此次销售的 SEC 文件提供了更多信息。该交易是在预先安排的 10b5-1 交易计划下执行的。出售是为了覆盖与股权奖励归属相关的税款扣缴义务。在过去的一个季度中，内部人士已出售 189,660 股公司股票，价值为 4,283,140 美元。公司内部人士持有公司股票的 24.39%。</p>
<h2>关于 Oscar Health</h2>
<p>（免费报告）</p>
<p>Oscar Health 在纽约证券交易所以 OSCR 的股票代码交易，是一家以技术驱动的健康保险公司，总部位于纽约。该公司由 Mario Schlosser、Joshua Kushner 和 Kevin Nazemi 于 2012 年创立，旨在简化医疗保险覆盖并提升会员体验。Oscar 利用专有的数字平台来简化计划注册、索赔管理和会员支持，在个人、家庭和小型团体保险市场中脱颖而出。</p>
<p>公司的主要产品包括根据《平价医疗法案》提供的交易所内个人和家庭医疗计划、交易所外计划以及医疗保险优势产品。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们认为比 Oscar Health 更好的股票</li>
<li>AI 服务器收益：华尔街看到一个明显的佼佼者</li>
<li>Navitas：NVIDIA 的 AI 权力经纪人？</li>
<li>Lululemon 的失误使其股价跌至新低——小心下面</li>
<li>NVIDIA 的新权力游戏：Fluence 为何在飙升</li>
</ul>
<p><strong>想看看其他对 OSCR 感兴趣的对冲基金持有哪些股票？</strong> 访问 HoldingsChannel.com，获取 Oscar Health, Inc.（NYSE:OSCR - 免费报告）的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Oscar Health 吗？</h2>
<p>在考虑 Oscar Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Oscar Health 并不在名单上。</p>
<p>虽然 Oscar Health 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

OSCR

OSCG

OSCX

<p>BIT Capital GmbH 在第四季度将其在 Oscar Health 的股份增加了 545%，购买了超过 520 万股。其他机构如 Quarry LP 和 Jones Financial 也显著增加了他们的持仓。与此同时，富国银行在每股收益超出预期后将 OSCR 的评级上调至 “持有”，尽管收入未能达到预期。分析师评级各不相同，Raymond James 上调至 “跑赢大盘”，而 Weiss 维持 “卖出” 评级</p>

<p>BIT Capital GmbH lifted its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 545.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 6,186,267 shares of the company's stock after purchasing an additional 5,227,152 shares during the quarter. Oscar Health comprises 3.3% of BIT Capital GmbH's portfolio, making the stock its 12th biggest holding. BIT Capital GmbH owned about 2.34% of Oscar Health worth $88,897,000 as of its most recent filing with the SEC.</p>
<div class="lb-trans"><p>BIT Capital GmbH 在最近向美国证券交易委员会提交的 13F 文件中表示，在第四季度将其在 Oscar Health, Inc. (NYSE:OSCR - 免费报告) 的持股比例提高了 545.0%。该公司在本季度额外购买了 5,227,152 股后，持有该公司 6,186,267 股股票。Oscar Health 占 BIT Capital GmbH 投资组合的 3.3%，成为其第 12 大持股。根据其最近向美国证券交易委员会提交的文件，BIT Capital GmbH 持有约 2.34% 的 Oscar Health，价值 88,897,000 美元。</p>
</div><ul>
<li>5 Small Cap Stocks With Explosive Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只具有爆炸性上涨潜力的小型股</li>
</ul>
</div><p>Several other hedge funds have also made changes to their positions in OSCR. Quarry LP increased its position in Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company's stock valued at $34,000 after buying an additional 1,469 shares in the last quarter. Jones Financial Companies Lllp increased its position in Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock valued at $30,000 after buying an additional 2,242 shares in the last quarter. Strs Ohio acquired a new position in Oscar Health during the 1st quarter valued at about $30,000. Fifth Third Bancorp grew its stake in Oscar Health by 148.7% during the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company's stock valued at $34,000 after purchasing an additional 1,413 shares during the last quarter. Finally, Binnacle Investments Inc purchased a new stake in shares of Oscar Health in the second quarter worth about $75,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他几家对冲基金也对 OSCR 的持仓进行了调整。Quarry LP 在第三季度将其在 Oscar Health 的持仓增加了 439.8%。Quarry LP 目前持有 1,803 股该公司的股票，价值 34,000 美元，此前在上个季度额外购买了 1,469 股。Jones Financial Companies Lllp 在第一季度将其在 Oscar Health 的持仓增加了 7,473.3%。Jones Financial Companies Lllp 目前持有 2,272 股该公司的股票，价值 30,000 美元，此前在上个季度额外购买了 2,242 股。Strs Ohio 在第一季度获得了 Oscar Health 的新持仓，价值约 30,000 美元。Fifth Third Bancorp 在第四季度将其在 Oscar Health 的持仓增加了 148.7%。Fifth Third Bancorp 目前持有 2,363 股该公司的股票，价值 34,000 美元，此前在上个季度额外购买了 1,413 股。最后，Binnacle Investments Inc 在第二季度购买了价值约 75,000 美元的 Oscar Health 股票。当前 75.70% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Key Oscar Health News</h2>
<div class="lb-trans"><h2>Oscar Health 关键新闻</h2>
</div><p>Here are the key news stories impacting Oscar Health this week:</p>
<div class="lb-trans"><p>以下是本周影响 Oscar Health 的关键新闻：</p>
</div><ul>
<li>Positive Sentiment: Wells Fargo upgraded Oscar Health from <strong>“strong sell” to “hold”</strong>, easing bearish sentiment even though its $20 target remains below the current share price. Zacks.com</li>
<li>Positive Sentiment: Oscar Health’s recent earnings showed a <strong>major EPS beat</strong>, which supports the stock’s fundamental story despite revenue coming in below estimates.</li>
<li>Neutral Sentiment: A company co-founder shifting into an <strong>advisory leadership role</strong> looks like an internal reorganization rather than a disruptive change. Oscar Health Co-Founder Shifts to Advisory Leadership Role</li>
<li>Neutral Sentiment: Multiple insiders, including <strong>CFO Richard Scott Blackley</strong> and <strong>CAO Victoria Baltrus</strong>, sold shares under pre-planned 10b5-1 programs to cover tax obligations on vested equity awards, which is less concerning than discretionary selling.</li>
<li>Negative Sentiment: Director <strong>Mario Schlosser</strong> sold <strong>34,120 shares</strong>, the largest insider sale in the latest batch, which may pressure sentiment even though it was pre-arranged.</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：富国银行将 Oscar Health 从 <strong>“强烈卖出” 上调至 “持有”</strong>，尽管其 20 美元的目标价仍低于当前股价，但缓解了看空情绪。Zacks.com</li>
<li>积极情绪：Oscar Health 最近的财报显示 <strong>大幅超出每股收益预期</strong>，尽管收入低于预期，但支持了该股的基本面故事。</li>
<li>中性情绪：一位公司联合创始人转任 <strong>顾问领导角色</strong>，看起来更像是内部重组，而不是颠覆性变化。Oscar Health 联合创始人转任顾问领导角色</li>
<li>中性情绪：多位内部人士，包括 <strong>首席财务官 Richard Scott Blackley</strong> 和 <strong>首席行政官 Victoria Baltrus</strong>，根据预先计划的 10b5-1 计划出售股票，以覆盖已归属股权奖励的税务义务，这比自愿出售的担忧要小。</li>
<li>消极情绪：董事 <strong>Mario Schlosser</strong> 出售了 <strong>34,120 股</strong>，这是最新一批中最大的一笔内部出售，尽管是预先安排的，但可能会对情绪造成压力。</li>
</ul>
</div><h2>Oscar Health Stock Performance</h2>
<div class="lb-trans"><h2>Oscar Health 股票表现</h2>
</div><p>OSCR opened at $24.59 on Friday. The stock has a market cap of $7.41 billion, a P/E ratio of -41.68, a P/E/G ratio of 1.65 and a beta of 2.37. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. The stock's 50 day simple moving average is $18.39 and its 200 day simple moving average is $16.06. Oscar Health, Inc. has a 1-year low of $10.69 and a 1-year high of $25.58.</p>
<div class="lb-trans"><p>OSCR 周五开盘价为 24.59 美元。该公司的市值为 74.1 亿美元，市盈率为 -41.68，市盈增长比率为 1.65，贝塔值为 2.37。该公司的债务与股本比率为 0.26，流动比率为 1.11，速动比率为 1.11。该股票的 50 日简单移动平均线为 18.39 美元，200 日简单移动平均线为 16.06 美元。Oscar Health, Inc. 的 1 年最低价为 10.69 美元，1 年最高价为 25.58 美元。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The business had revenue of $4.65 billion for the quarter, compared to analysts' expectations of $4.90 billion. During the same quarter in the prior year, the firm posted $0.92 EPS. The company's revenue was up 52.6% compared to the same quarter last year. As a group, equities analysts anticipate that Oscar Health, Inc. will post 0.47 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Oscar Health (NYSE:OSCR - 获取免费报告) 最近于 5 月 6 日发布了季度财报。该公司报告本季度每股收益为 2.07 美元，超出分析师一致预期的 1.11 美元，超出幅度为 0.96 美元。Oscar Health 的股本回报率为 -3.26%，净利润率为 -0.30%。该业务本季度的收入为 46.5 亿美元，而分析师预期为 49 亿美元。去年同期，该公司每股收益为 0.92 美元。与去年同期相比，该公司的收入增长了 52.6%。整体来看，股票分析师预计 Oscar Health, Inc. 本财年将发布 0.47 美元的每股收益。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>OSCR has been the topic of a number of recent research reports. Raymond James Financial upgraded Oscar Health from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $18.00 target price on the stock in a research note on Thursday, February 12th. Weiss Ratings reiterated a &#34;sell (d)&#34; rating on shares of Oscar Health in a research report on Tuesday, April 21st. Wells Fargo &amp; Company set a $20.00 price target on Oscar Health and gave the company an &#34;equal weight&#34; rating in a report on Thursday. Wall Street Zen cut Oscar Health from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a report on Saturday. Finally, Zacks Research raised Oscar Health from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of &#34;Hold&#34; and a consensus price target of $20.22.</p>
<div class="lb-trans"><p>OSCR 最近成为多份研究报告的主题。Raymond James Financial 将 Oscar Health 的评级从 &#34;市场表现&#34; 上调至 &#34;跑赢大盘&#34;，并在 2 月 12 日的研究报告中设定了 18.00 美元的目标价。Weiss Ratings 在 4 月 21 日的研究报告中重申了对 Oscar Health 股票的 &#34;卖出 (d)&#34; 评级。富国银行在周四设定了 Oscar Health 的 20.00 美元目标价，并给予该公司 &#34;等权重&#34; 评级。Wall Street Zen 在周六的报告中将 Oscar Health 的评级从 &#34;强力买入&#34; 下调至 &#34;买入&#34;。最后，Zacks Research 在 5 月 7 日的研究报告中将 Oscar Health 的评级从 &#34;持有&#34; 上调至 &#34;强力买入&#34;。一位研究分析师对该股票给予了强力买入评级，两位给予了买入评级，八位给予了持有评级，一位给予了卖出评级。根据 MarketBeat 的数据，该公司目前的共识评级为 &#34;持有&#34;，共识目标价为 20.22 美元。</p>
</div><p><strong>View Our Latest Report on OSCR</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 OSCR 的最新报告</strong></p>
</div><h2>Insider Activity at Oscar Health</h2>
<div class="lb-trans"><h2>Oscar Health 的内部活动</h2>
</div><p>In other Oscar Health news, CEO Mark T. Bertolini purchased 1,000,000 shares of Oscar Health stock in a transaction on Monday, April 6th. The shares were bought at an average price of $11.92 per share, with a total value of $11,920,000.00. Following the purchase, the chief executive officer directly owned 10,196,876 shares in the company, valued at $121,546,761.92. This trade represents a 10.87% increase in their position. The acquisition was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available at the SEC website. Also, Director Mario Schlosser sold 34,120 shares of the stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $748,592.80. Following the transaction, the director directly owned 480,866 shares in the company, valued at approximately $10,550,200.04. This represents a 6.63% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 189,660 shares of company stock worth $4,283,140. Company insiders own 24.39% of the company's stock.</p>
<div class="lb-trans"><p>在关于 Oscar Health 的其他消息中，首席执行官 Mark T. Bertolini 于 4 月 6 日星期一购买了 1,000,000 股 Oscar Health 股票。每股的平均购买价格为 11.92 美元，总价值为 11,920,000.00 美元。购买后，首席执行官直接持有公司 10,196,876 股，价值为 121,546,761.92 美元。这笔交易代表了其持股比例的 10.87% 的增加。此次收购在向证券交易委员会的法律文件中披露，该文件可在 SEC 网站上查阅。此外，董事 Mario Schlosser 于 6 月 2 日星期二出售了 34,120 股该股票。股票的平均售价为 21.94 美元，总价值为 748,592.80 美元。交易后，该董事直接持有公司 480,866 股，价值约为 10,550,200.04 美元。这代表其持股比例的 6.63% 的减少。此次销售的 SEC 文件提供了更多信息。该交易是在预先安排的 10b5-1 交易计划下执行的。出售是为了覆盖与股权奖励归属相关的税款扣缴义务。在过去的一个季度中，内部人士已出售 189,660 股公司股票，价值为 4,283,140 美元。公司内部人士持有公司股票的 24.39%。</p>
</div><h2>About Oscar Health</h2>
<div class="lb-trans"><h2>关于 Oscar Health</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.</p>
<div class="lb-trans"><p>Oscar Health 在纽约证券交易所以 OSCR 的股票代码交易，是一家以技术驱动的健康保险公司，总部位于纽约。该公司由 Mario Schlosser、Joshua Kushner 和 Kevin Nazemi 于 2012 年创立，旨在简化医疗保险覆盖并提升会员体验。Oscar 利用专有的数字平台来简化计划注册、索赔管理和会员支持，在个人、家庭和小型团体保险市场中脱颖而出。</p>
</div><p>The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.</p>
<div class="lb-trans"><p>公司的主要产品包括根据《平价医疗法案》提供的交易所内个人和家庭医疗计划、交易所外计划以及医疗保险优势产品。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>AI Server Earnings: Wall Street Sees One Clear Standout</li>
<li>Navitas: NVIDIA’s AI Power Broker?</li>
<li>A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below</li>
<li>NVIDIA's New Power Play: Why Fluence Is Surging</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 Oscar Health 更好的股票</li>
<li>AI 服务器收益：华尔街看到一个明显的佼佼者</li>
<li>Navitas：NVIDIA 的 AI 权力经纪人？</li>
<li>Lululemon 的失误使其股价跌至新低——小心下面</li>
<li>NVIDIA 的新权力游戏：Fluence 为何在飙升</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding OSCR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 OSCR 感兴趣的对冲基金持有哪些股票？</strong> 访问 HoldingsChannel.com，获取 Oscar Health, Inc.（NYSE:OSCR - 免费报告）的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=OSCR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Oscar Health 吗？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Oscar Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Oscar Health 并不在名单上。</p>
</div><p>While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Oscar Health 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

BIT Capital GmbH Purchases 5,227,152 Shares of Oscar Health, Inc. $OSCR

Market Beat

Oscar Health

Leverage Shares 2X Long OSCR Daily ETF

Defiance Daily Target 2x Long OSCR ETF

五三银行

富国银行

瑞杰金融

五三银行-存托优先股Series K

Fifth Third Bancorp Pref Shares FITBM 6.875 Perp 10/01/30

五三银行-Series A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

RAYMOND JAMES FINANCIAL INC 6.375%DEP SHS REP 1/40TH FXD FLTG SER B

BIT Capital GmbH 购买了 5,227,152 股 Oscar Health, Inc.（Oscar Health）的股票